astrial_astrial

*** 次数：1999998 已用完，请联系开发者***

中国生物制药(01177):“盐酸安罗替尼胶囊”、“TQB2916(CD40激动...如下:临床研究1. 安罗替尼:消化道肿瘤编号:CT213/13摘要标题:Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort C内容概要:ALTER-G-00...

中国生物制药(01177):“盐酸安罗替尼胶囊”、“TQB2916(CD40激动...如下:临床研究1. 安罗替尼:消化道肿瘤编号:CT213/13摘要标题:Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort C内容概要:ALTER-G-00...

中国生物制药(01177):“盐酸安罗替尼胶囊”、“TQB2916(CD40激动...临床研究:安罗替尼:消化道肿瘤编号:CT213/13摘要标题:Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G001-cohort C安罗替尼:小细胞肺癌编号:509...

中国生物制药(01177):“盐酸安罗替尼胶囊”、“TQB2916(CD40激动...临床研究:安罗替尼:消化道肿瘤编号:CT213/13摘要标题:Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G001-cohort C安罗替尼:小细胞肺癌编号:509...